Biogen (NASDAQ:BIIB – Free Report) had its price target decreased by BMO Capital Markets from $156.00 to $139.00 in a report ...
The banking sector seems to be performing well in 2025 as the economy has been stronger than expected. Banking and financial ...
Albemarle (NYSE:ALB – Free Report) had its target price reduced by BMO Capital Markets from $150.00 to $140.00 in a research ...
BMO Capital Markets. "As the industry evolves, our priority is providing exceptional service to our clients while delivering more integrated and innovative solutions to grow our market leading ...
Stocks came within a striking distance of their all-time highs while the dollar got hit as President Donald Trump moved to ...
BMO Capital Markets adjusted its price target on shares of TC Energy (NYSE:TRP:CN) (NYSE: TRP), reducing it from Cdn$73.00 to Cdn$71.00. Despite this change, the firm kept its Market Perform rating ...
BMO Capital Markets. "As the industry evolves, our priority is providing exceptional service to our clients while delivering more integrated and innovative solutions to grow our market leading ...
On Tuesday, BMO Capital Markets reaffirmed their Outperform rating on Beam Therapeutics Inc (NASDAQ:BEAM), with a steady price target of $57.00. Currently trading at $26.57, the stock appears ...
Signs of resurgent inflation shown in January's consumer-price index can't be "easily explained away" by seasonal factors, and pressure will build on the Federal Reserve to stay on hold for a ...
Wednesday afternoon's sale of $42 billion in 10-year notes tailed by 1 basis point and was met with non-dealer bidding that was slightly below average, according to BMO Capital Markets strategist Vail ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results